Author

P. Hombrink

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. E. Oja· 2 shared C. A. Ghandour· 2 shared R. A. W. van Lier· 2 shared A. Saris· 1 shared A. Ten Brinke· 1 shared B. M. Hogema· 1 shared B. W. Bardoel· 1 shared E. J. Nossent· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. E. Oja

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintFeb 16, 2022

Polyfunctional pathogen-specific CD4+ T cells reside in the lungs and tumors of NSCLC patients

A. E. Oja, F. Morgana, R. Hagen…·P. Hombrink

The paper identifies polyfunctional pathogen-specific CD4+ T cells in lung and NSCLC tumor tissues, highlighting their potential for vaccine design and anti-tumor immunity.

DOI 10.1101/2022.02.16.479923

humanflow cytometry

𝕏 PostBluesky

ImmunologybioRxivPreprintJun 18, 2020

Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19

A. E. Oja, A. Saris, C. A. Ghandour…·P. Hombrink

The paper compares T and B cell responses in severe versus mild COVID-19 patients, finding impaired CD4+ T cell responses but strong IgG antibodies in severe cases.

DOI 10.1101/2020.06.18.159202

humanproteomics

𝕏 PostBluesky